Pubblicazioni

Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis

2023 - ANTICANCER RESEARCH
Marrocco, G. A.; Silletta, M.; Bianco, V.; Mondera, F.; Sciortino, C.; Pappalardo, L.; Viglialoro, V.; Cortesi, E.; Tonini, G.; Caponnetto, S.

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY
Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

Predictors of response and survival to multikinase inhibitors in radioiodine resistant differentiated thyroid cancer

2021 - JOURNAL OF PERSONALIZED MEDICINE
Feola, T.; Cozzolino, A.; Centello, R.; Pandozzi, C.; Tarsitano, M. G.; Giannetta, E.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma